APO Research
Talk to an analyst

APO RESEARCH · REPORT

Montelukast Intermediate

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Montelukast Intermediate Market Analysis and Forecast 2026-2032

20 December 2025196 pages

Choose your research edition.

Industry ResearchMontelukast Intermediate Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Montelukast Intermediate Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Montelukast Intermediate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Montelukast Intermediate Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Montelukast Intermediate Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Montelukast Intermediate market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Montelukast Intermediate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Montelukast Intermediate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Montelukast Intermediate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Montelukast Intermediate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Montelukast Intermediate include VIVAN Life Sciences, P.G. Shah & Co., Ortin Laboratories and Manus Aktteva Biopharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Montelukast Intermediate, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Montelukast Intermediate, also provides the sales of main regions and countries. Of the upcoming market potential for Montelukast Intermediate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Montelukast Intermediate sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Montelukast Intermediate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Montelukast Intermediate sales, projected growth trends, production technology, application and end-user industry.

Montelukast Intermediate Segment by Company

VIVAN Life Sciences

P.G. Shah & Co.

Ortin Laboratories

Manus Aktteva Biopharma

Montelukast Intermediate Segment by Type

GMP

Non-GMP

Montelukast Intermediate Segment by Application

Bronchospasm

Urticaria

Asthma

Allergic Rhinitis

Montelukast Intermediate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Intermediate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Montelukast Intermediate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Intermediate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Montelukast Intermediate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Montelukast Intermediate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Montelukast Intermediate sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Montelukast Intermediate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. GMP Major Manufacturers Table 3. Non-GMP Major Manufacturers Table 4. Global Montelukast Intermediate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Bronchospasm Major Manufacturers Table 6. Urticaria Major Manufacturers Table 7. Asthma Major Manufacturers Table 8. Allergic Rhinitis Major Manufacturers Table 9. Montelukast Intermediate Industry Trends Table 10. Montelukast Intermediate Industry Drivers Table 11. Montelukast Intermediate Industry Opportunities and Challenges Table 12. Montelukast Intermediate Industry Restraints Table 13. Global Montelukast Intermediate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Montelukast Intermediate Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Montelukast Intermediate Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Montelukast Intermediate Revenue Market Share by Region (2021-2026) Table 17. Global Montelukast Intermediate Revenue Market Share by Region (2027-2032) Table 18. Global Montelukast Intermediate Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 19. Global Montelukast Intermediate Sales by Region (2021-2026) & (tons) Table 20. Global Montelukast Intermediate Sales by Region (2027-2032) & (tons) Table 21. Global Montelukast Intermediate Sales Market Share by Region (2021-2026) Table 22. Global Montelukast Intermediate Sales Market Share by Region (2027-2032) Table 23. Global Montelukast Intermediate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Montelukast Intermediate Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Montelukast Intermediate Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Montelukast Intermediate Sales Market Share by Manufacturers (2021-2026) Table 27. Global Montelukast Intermediate Sales Price (US$/ton) of Manufacturers (2021-2026) Table 28. Global Montelukast Intermediate Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Montelukast Intermediate Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Montelukast Intermediate Manufacturers, Product Type & Application Table 31. Global Montelukast Intermediate Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Montelukast Intermediate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Montelukast Intermediate Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Montelukast Intermediate Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Montelukast Intermediate Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Montelukast Intermediate Revenue Market Share by Type (2021-2026) Table 38. Global Montelukast Intermediate Revenue Market Share by Type (2027-2032) Table 39. Global Montelukast Intermediate Sales by Type 2021 VS 2025 VS 2032 (tons) Table 40. Global Montelukast Intermediate Sales by Type (2021-2026) & (tons) Table 41. Global Montelukast Intermediate Sales by Type (2027-2032) & (tons) Table 42. Global Montelukast Intermediate Sales Market Share by Type (2021-2026) Table 43. Global Montelukast Intermediate Sales Market Share by Type (2027-2032) Table 44. Global Montelukast Intermediate Price by Type (2021-2026) & (US$/ton) Table 45. Global Montelukast Intermediate Price by Type (2027-2032) & (US$/ton) Table 46. Global Montelukast Intermediate Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Montelukast Intermediate Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Montelukast Intermediate Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Montelukast Intermediate Revenue Market Share by Application (2021-2026) Table 50. Global Montelukast Intermediate Revenue Market Share by Application (2027-2032) Table 51. Global Montelukast Intermediate Sales by Application 2021 VS 2025 VS 2032 (tons) Table 52. Global Montelukast Intermediate Sales by Application (2021-2026) & (tons) Table 53. Global Montelukast Intermediate Sales by Application (2027-2032) & (tons) Table 54. Global Montelukast Intermediate Sales Market Share by Application (2021-2026) Table 55. Global Montelukast Intermediate Sales Market Share by Application (2027-2032) Table 56. Global Montelukast Intermediate Price by Application (2021-2026) & (US$/ton) Table 57. Global Montelukast Intermediate Price by Application (2027-2032) & (US$/ton) Table 58. VIVAN Life Sciences Company Information Table 59. VIVAN Life Sciences Business Overview Table 60. VIVAN Life Sciences Montelukast Intermediate Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 61. VIVAN Life Sciences Montelukast Intermediate Product Portfolio Table 62. VIVAN Life Sciences Recent Development Table 63. P.G. Shah & Co. Company Information Table 64. P.G. Shah & Co. Business Overview Table 65. P.G. Shah & Co. Montelukast Intermediate Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 66. P.G. Shah & Co. Montelukast Intermediate Product Portfolio Table 67. P.G. Shah & Co. Recent Development Table 68. Ortin Laboratories Company Information Table 69. Ortin Laboratories Business Overview Table 70. Ortin Laboratories Montelukast Intermediate Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 71. Ortin Laboratories Montelukast Intermediate Product Portfolio Table 72. Ortin Laboratories Recent Development Table 73. Manus Aktteva Biopharma Company Information Table 74. Manus Aktteva Biopharma Business Overview Table 75. Manus Aktteva Biopharma Montelukast Intermediate Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Manus Aktteva Biopharma Montelukast Intermediate Product Portfolio Table 77. Manus Aktteva Biopharma Recent Development Table 78. North America Montelukast Intermediate Revenue by Type (2021-2026) & (US$ Million) Table 79. North America Montelukast Intermediate Revenue by Type (2027-2032) & (US$ Million) Table 80. North America Montelukast Intermediate Sales by Type (2021-2026) & (tons) Table 81. North America Montelukast Intermediate Sales by Type (2027-2032) & (tons) Table 82. North America Montelukast Intermediate Sales Price by Type (2021-2026) & (US$/ton) Table 83. North America Montelukast Intermediate Sales Price by Type (2027-2032) & (US$/ton) Table 84. North America Montelukast Intermediate Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Montelukast Intermediate Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Montelukast Intermediate Sales by Application (2021-2026) & (tons) Table 87. North America Montelukast Intermediate Sales by Application (2027-2032) & (tons) Table 88. North America Montelukast Intermediate Sales Price by Application (2021-2026) & (US$/ton) Table 89. North America Montelukast Intermediate Sales Price by Application (2027-2032) & (US$/ton) Table 90. North America Montelukast Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Montelukast Intermediate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 92. North America Montelukast Intermediate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 93. North America Montelukast Intermediate Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 94. North America Montelukast Intermediate Sales by Country (2021-2026) & (tons) Table 95. North America Montelukast Intermediate Sales by Country (2027-2032) & (tons) Table 96. North America Montelukast Intermediate Sales Price by Country (2021-2026) & (US$/ton) Table 97. North America Montelukast Intermediate Sales Price by Country (2027-2032) & (US$/ton) Table 98. United States Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 99. Canada Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 100. Mexico Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 101. Europe Montelukast Intermediate Revenue by Type (2021-2026) & (US$ Million) Table 102. Europe Montelukast Intermediate Revenue by Type (2027-2032) & (US$ Million) Table 103. Europe Montelukast Intermediate Sales by Type (2021-2026) & (tons) Table 104. Europe Montelukast Intermediate Sales by Type (2027-2032) & (tons) Table 105. Europe Montelukast Intermediate Sales Price by Type (2021-2026) & (US$/ton) Table 106. Europe Montelukast Intermediate Sales Price by Type (2027-2032) & (US$/ton) Table 107. Europe Montelukast Intermediate Revenue by Application (2021-2026) & (US$ Million) Table 108. Europe Montelukast Intermediate Revenue by Application (2027-2032) & (US$ Million) Table 109. Europe Montelukast Intermediate Sales by Application (2021-2026) & (tons) Table 110. Europe Montelukast Intermediate Sales by Application (2027-2032) & (tons) Table 111. Europe Montelukast Intermediate Sales Price by Application (2021-2026) & (US$/ton) Table 112. Europe Montelukast Intermediate Sales Price by Application (2027-2032) & (US$/ton) Table 113. Europe Montelukast Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Montelukast Intermediate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. Europe Montelukast Intermediate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. Europe Montelukast Intermediate Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 117. Europe Montelukast Intermediate Sales by Country (2021-2026) & (tons) Table 118. Europe Montelukast Intermediate Sales by Country (2027-2032) & (tons) Table 119. Europe Montelukast Intermediate Sales Price by Country (2021-2026) & (US$/ton) Table 120. Europe Montelukast Intermediate Sales Price by Country (2027-2032) & (US$/ton) Table 121. Germany Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 122. France Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 123. U.K. Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 124. Italy Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 125. Russia Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 126. Spain Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 127. Netherlands Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 128. Switzerland Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 129. Sweden Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 130. Poland Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 131. China Montelukast Intermediate Revenue by Type (2021-2026) & (US$ Million) Table 132. China Montelukast Intermediate Revenue by Type (2027-2032) & (US$ Million) Table 133. China Montelukast Intermediate Sales by Type (2021-2026) & (tons) Table 134. China Montelukast Intermediate Sales by Type (2027-2032) & (tons) Table 135. China Montelukast Intermediate Sales Price by Type (2021-2026) & (US$/ton) Table 136. China Montelukast Intermediate Sales Price by Type (2027-2032) & (US$/ton) Table 137. China Montelukast Intermediate Revenue by Application (2021-2026) & (US$ Million) Table 138. China Montelukast Intermediate Revenue by Application (2027-2032) & (US$ Million) Table 139. China Montelukast Intermediate Sales by Application (2021-2026) & (tons) Table 140. China Montelukast Intermediate Sales by Application (2027-2032) & (tons) Table 141. China Montelukast Intermediate Sales Price by Application (2021-2026) & (US$/ton) Table 142. China Montelukast Intermediate Sales Price by Application (2027-2032) & (US$/ton) Table 143. Asia Montelukast Intermediate Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Montelukast Intermediate Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Montelukast Intermediate Sales by Type (2021-2026) & (tons) Table 146. Asia Montelukast Intermediate Sales by Type (2027-2032) & (tons) Table 147. Asia Montelukast Intermediate Sales Price by Type (2021-2026) & (US$/ton) Table 148. Asia Montelukast Intermediate Sales Price by Type (2027-2032) & (US$/ton) Table 149. Asia Montelukast Intermediate Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia Montelukast Intermediate Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Montelukast Intermediate Sales by Application (2021-2026) & (tons) Table 152. Asia Montelukast Intermediate Sales by Application (2027-2032) & (tons) Table 153. Asia Montelukast Intermediate Sales Price by Application (2021-2026) & (US$/ton) Table 154. Asia Montelukast Intermediate Sales Price by Application (2027-2032) & (US$/ton) Table 155. Asia Montelukast Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Asia Montelukast Intermediate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. Asia Montelukast Intermediate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. Asia Montelukast Intermediate Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 159. Asia Montelukast Intermediate Sales by Country (2021-2026) & (tons) Table 160. Asia Montelukast Intermediate Sales by Country (2027-2032) & (tons) Table 161. Asia Montelukast Intermediate Sales Price by Country (2021-2026) & (US$/ton) Table 162. Asia Montelukast Intermediate Sales Price by Country (2027-2032) & (US$/ton) Table 163. Japan Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 164. South Korea Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 165. India Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 166. Australia Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 167. Taiwan Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 168. Southeast Asia Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 169. SAMEA Montelukast Intermediate Revenue by Type (2021-2026) & (US$ Million) Table 170. SAMEA Montelukast Intermediate Revenue by Type (2027-2032) & (US$ Million) Table 171. SAMEA Montelukast Intermediate Sales by Type (2021-2026) & (tons) Table 172. SAMEA Montelukast Intermediate Sales by Type (2027-2032) & (tons) Table 173. SAMEA Montelukast Intermediate Sales Price by Type (2021-2026) & (US$/ton) Table 174. SAMEA Montelukast Intermediate Sales Price by Type (2027-2032) & (US$/ton) Table 175. SAMEA Montelukast Intermediate Revenue by Application (2021-2026) & (US$ Million) Table 176. SAMEA Montelukast Intermediate Revenue by Application (2027-2032) & (US$ Million) Table 177. SAMEA Montelukast Intermediate Sales by Application (2021-2026) & (tons) Table 178. SAMEA Montelukast Intermediate Sales by Application (2027-2032) & (tons) Table 179. SAMEA Montelukast Intermediate Sales Price by Application (2021-2026) & (US$/ton) Table 180. SAMEA Montelukast Intermediate Sales Price by Application (2027-2032) & (US$/ton) Table 181. SAMEA Montelukast Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. SAMEA Montelukast Intermediate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. SAMEA Montelukast Intermediate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. SAMEA Montelukast Intermediate Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 185. SAMEA Montelukast Intermediate Sales by Country (2021-2026) & (tons) Table 186. SAMEA Montelukast Intermediate Sales by Country (2027-2032) & (tons) Table 187. SAMEA Montelukast Intermediate Sales Price by Country (2021-2026) & (US$/ton) Table 188. SAMEA Montelukast Intermediate Sales Price by Country (2027-2032) & (US$/ton) Table 189. Brazil Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 190. Argentina Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 191. Chile Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 192. Colombia Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 193. Peru Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 194. Saudi Arabia Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 195. Israel Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 196. UAE Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 197. Turkey Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 198. Iran Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 199. Egypt Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. Montelukast Intermediate Distributors List Table 203. Montelukast Intermediate Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. Montelukast Intermediate Image Figure 2. Global Montelukast Intermediate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Montelukast Intermediate Market Size Share 2021 VS 2025 VS 2032 Figure 4. GMP Image Figure 5. Non-GMP Image Figure 6. Global Montelukast Intermediate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Montelukast Intermediate Market Size Share 2021 VS 2025 VS 2032 Figure 8. Bronchospasm Image Figure 9. Urticaria Image Figure 10. Asthma Image Figure 11. Allergic Rhinitis Image Figure 12. Global Montelukast Intermediate Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Montelukast Intermediate Revenue (2021-2032) & (US$ Million) Figure 14. Global Montelukast Intermediate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Montelukast Intermediate Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Montelukast Intermediate Revenue Market Share by Region (2021-2032) Figure 17. Global Montelukast Intermediate Sales (2021-2032) & (tons) Figure 18. Global Montelukast Intermediate Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 19. Global Montelukast Intermediate Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Montelukast Intermediate Sales YoY (2021-2032) & (tons) Figure 21. Europe Montelukast Intermediate Sales YoY (2021-2032) & (tons) Figure 22. China Montelukast Intermediate Sales YoY (2021-2032) & (tons) Figure 23. Asia (Excluding China) Montelukast Intermediate Sales YoY (2021-2032) & (tons) Figure 24. South America, Middle East and Africa Montelukast Intermediate Sales YoY (2021-2032) & (tons) Figure 25. Global Montelukast Intermediate Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Montelukast Intermediate Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Montelukast Intermediate Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Montelukast Intermediate Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Montelukast Intermediate Revenue Market Share by Type (2021-2032) Figure 31. Global Montelukast Intermediate Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 32. Global Montelukast Intermediate Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Montelukast Intermediate Sales Market Share by Type (2021-2032) Figure 34. Global Montelukast Intermediate Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Montelukast Intermediate Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Montelukast Intermediate Revenue Market Share by Application (2021-2032) Figure 37. Global Montelukast Intermediate Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 38. Global Montelukast Intermediate Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Montelukast Intermediate Sales Market Share by Application (2021-2032) Figure 40. North America Montelukast Intermediate Revenue Share by Type (2021-2032) Figure 41. North America Montelukast Intermediate Sales Share by Type (2021-2032) Figure 42. North America Montelukast Intermediate Revenue Share by Application (2021-2032) Figure 43. North America Montelukast Intermediate Sales Share by Application (2021-2032) Figure 44. North America Montelukast Intermediate Revenue Share by Country (2021-2032) Figure 45. North America Montelukast Intermediate Sales Share by Country (2021-2032) Figure 46. Europe Montelukast Intermediate Revenue Share by Type (2021-2032) Figure 47. Europe Montelukast Intermediate Sales Share by Type (2021-2032) Figure 48. Europe Montelukast Intermediate Revenue Share by Application (2021-2032) Figure 49. Europe Montelukast Intermediate Sales Share by Application (2021-2032) Figure 50. Europe Montelukast Intermediate Revenue Share by Country (2021-2032) Figure 51. Europe Montelukast Intermediate Sales Share by Country (2021-2032) Figure 52. China Montelukast Intermediate Revenue Share by Type (2021-2032) Figure 53. China Montelukast Intermediate Sales Share by Type (2021-2032) Figure 54. China Montelukast Intermediate Revenue Share by Application (2021-2032) Figure 55. China Montelukast Intermediate Sales Share by Application (2021-2032) Figure 56. Asia Montelukast Intermediate Revenue Share by Type (2021-2032) Figure 57. Asia Montelukast Intermediate Sales Share by Type (2021-2032) Figure 58. Asia Montelukast Intermediate Revenue Share by Application (2021-2032) Figure 59. Asia Montelukast Intermediate Sales Share by Application (2021-2032) Figure 60. Asia Montelukast Intermediate Revenue Share by Country (2021-2032) Figure 61. Asia Montelukast Intermediate Sales Share by Country (2021-2032) Figure 62. SAMEA Montelukast Intermediate Revenue Share by Type (2021-2032) Figure 63. SAMEA Montelukast Intermediate Sales Share by Type (2021-2032) Figure 64. SAMEA Montelukast Intermediate Revenue Share by Application (2021-2032) Figure 65. SAMEA Montelukast Intermediate Sales Share by Application (2021-2032) Figure 66. SAMEA Montelukast Intermediate Revenue Share by Country (2021-2032) Figure 67. SAMEA Montelukast Intermediate Sales Share by Country (2021-2032) Figure 68. Montelukast Intermediate Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Montelukast Intermediate Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • GMP
  • Non-GMP
Applications
  • Bronchospasm
  • Urticaria
  • Asthma
  • Allergic Rhinitis
Companies covered
  • VIVAN Life Sciences
  • P.G. Shah & Co.
  • Ortin Laboratories
  • Manus Aktteva Biopharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Montelukast Intermediate Market by Type
  3. 1.2.1 Global Montelukast Intermediate Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 GMP
  5. 1.2.3 Non-GMP
  6. 1.3 Montelukast Intermediate Market by Application
  7. 1.3.1 Global Montelukast Intermediate Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Bronchospasm
  9. 1.3.3 Urticaria
  10. 1.3.4 Asthma
  11. 1.3.5 Allergic Rhinitis
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Montelukast Intermediate Market Dynamics
  1. 2.1 Montelukast Intermediate Industry Trends
  2. 2.2 Montelukast Intermediate Industry Drivers
  3. 2.3 Montelukast Intermediate Industry Opportunities and Challenges
  4. 2.4 Montelukast Intermediate Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Montelukast Intermediate Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Montelukast Intermediate Revenue by Region
  3. 3.2.1 Global Montelukast Intermediate Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Montelukast Intermediate Revenue by Region (2021-2026)
  5. 3.2.3 Global Montelukast Intermediate Revenue by Region (2027-2032)
  6. 3.2.4 Global Montelukast Intermediate Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Montelukast Intermediate Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Montelukast Intermediate Sales by Region
  9. 3.4.1 Global Montelukast Intermediate Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Montelukast Intermediate Sales by Region (2021-2026)
  11. 3.4.3 Global Montelukast Intermediate Sales by Region (2027-2032)
  12. 3.4.4 Global Montelukast Intermediate Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Montelukast Intermediate Revenue by Manufacturers
  2. 4.1.1 Global Montelukast Intermediate Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Montelukast Intermediate Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Montelukast Intermediate Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Montelukast Intermediate Sales by Manufacturers
  6. 4.2.1 Global Montelukast Intermediate Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Montelukast Intermediate Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Montelukast Intermediate Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Montelukast Intermediate Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Montelukast Intermediate Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Montelukast Intermediate Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Montelukast Intermediate Manufacturers, Product Type & Application
  13. 4.7 Global Montelukast Intermediate Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Montelukast Intermediate Market CR5 and HHI
  16. 4.8.2 2025 Montelukast Intermediate Tier 1, Tier 2, and Tier 3
5 Montelukast Intermediate Market by Type
  1. 5.1 Global Montelukast Intermediate Revenue by Type
  2. 5.1.1 Global Montelukast Intermediate Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Montelukast Intermediate Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Montelukast Intermediate Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Montelukast Intermediate Sales by Type
  6. 5.2.1 Global Montelukast Intermediate Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Montelukast Intermediate Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Montelukast Intermediate Sales Market Share by Type (2021-2032)
  9. 5.3 Global Montelukast Intermediate Price by Type
6 Montelukast Intermediate Market by Application
  1. 6.1 Global Montelukast Intermediate Revenue by Application
  2. 6.1.1 Global Montelukast Intermediate Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Montelukast Intermediate Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Montelukast Intermediate Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Montelukast Intermediate Sales by Application
  6. 6.2.1 Global Montelukast Intermediate Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Montelukast Intermediate Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Montelukast Intermediate Sales Market Share by Application (2021-2032)
  9. 6.3 Global Montelukast Intermediate Price by Application
7 Company Profiles
  1. 7.1 VIVAN Life Sciences
  2. 7.1.1 VIVAN Life Sciences Company Information
  3. 7.1.2 VIVAN Life Sciences Business Overview
  4. 7.1.3 VIVAN Life Sciences Montelukast Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 VIVAN Life Sciences Montelukast Intermediate Product Portfolio
  6. 7.1.5 VIVAN Life Sciences Recent Developments
  7. 7.2 P.G. Shah & Co.
  8. 7.2.1 P.G. Shah & Co. Company Information
  9. 7.2.2 P.G. Shah & Co. Business Overview
  10. 7.2.3 P.G. Shah & Co. Montelukast Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 P.G. Shah & Co. Montelukast Intermediate Product Portfolio
  12. 7.2.5 P.G. Shah & Co. Recent Developments
  13. 7.3 Ortin Laboratories
  14. 7.3.1 Ortin Laboratories Company Information
  15. 7.3.2 Ortin Laboratories Business Overview
  16. 7.3.3 Ortin Laboratories Montelukast Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ortin Laboratories Montelukast Intermediate Product Portfolio
  18. 7.3.5 Ortin Laboratories Recent Developments
  19. 7.4 Manus Aktteva Biopharma
  20. 7.4.1 Manus Aktteva Biopharma Company Information
  21. 7.4.2 Manus Aktteva Biopharma Business Overview
  22. 7.4.3 Manus Aktteva Biopharma Montelukast Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Manus Aktteva Biopharma Montelukast Intermediate Product Portfolio
  24. 7.4.5 Manus Aktteva Biopharma Recent Developments
8 North America
  1. 8.1 North America Montelukast Intermediate Market Size by Type
  2. 8.1.1 North America Montelukast Intermediate Revenue by Type (2021-2032)
  3. 8.1.2 North America Montelukast Intermediate Sales by Type (2021-2032)
  4. 8.1.3 North America Montelukast Intermediate Price by Type (2021-2032)
  5. 8.2 North America Montelukast Intermediate Market Size by Application
  6. 8.2.1 North America Montelukast Intermediate Revenue by Application (2021-2032)
  7. 8.2.2 North America Montelukast Intermediate Sales by Application (2021-2032)
  8. 8.2.3 North America Montelukast Intermediate Price by Application (2021-2032)
  9. 8.3 North America Montelukast Intermediate Market Size by Country
  10. 8.3.1 North America Montelukast Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Montelukast Intermediate Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Montelukast Intermediate Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Montelukast Intermediate Market Size by Type
  2. 9.1.1 Europe Montelukast Intermediate Revenue by Type (2021-2032)
  3. 9.1.2 Europe Montelukast Intermediate Sales by Type (2021-2032)
  4. 9.1.3 Europe Montelukast Intermediate Price by Type (2021-2032)
  5. 9.2 Europe Montelukast Intermediate Market Size by Application
  6. 9.2.1 Europe Montelukast Intermediate Revenue by Application (2021-2032)
  7. 9.2.2 Europe Montelukast Intermediate Sales by Application (2021-2032)
  8. 9.2.3 Europe Montelukast Intermediate Price by Application (2021-2032)
  9. 9.3 Europe Montelukast Intermediate Market Size by Country
  10. 9.3.1 Europe Montelukast Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Montelukast Intermediate Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Montelukast Intermediate Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Montelukast Intermediate Market Size by Type
  2. 10.1.1 China Montelukast Intermediate Revenue by Type (2021-2032)
  3. 10.1.2 China Montelukast Intermediate Sales by Type (2021-2032)
  4. 10.1.3 China Montelukast Intermediate Price by Type (2021-2032)
  5. 10.2 China Montelukast Intermediate Market Size by Application
  6. 10.2.1 China Montelukast Intermediate Revenue by Application (2021-2032)
  7. 10.2.2 China Montelukast Intermediate Sales by Application (2021-2032)
  8. 10.2.3 China Montelukast Intermediate Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Montelukast Intermediate Market Size by Type
  2. 11.1.1 Asia Montelukast Intermediate Revenue by Type (2021-2032)
  3. 11.1.2 Asia Montelukast Intermediate Sales by Type (2021-2032)
  4. 11.1.3 Asia Montelukast Intermediate Price by Type (2021-2032)
  5. 11.2 Asia Montelukast Intermediate Market Size by Application
  6. 11.2.1 Asia Montelukast Intermediate Revenue by Application (2021-2032)
  7. 11.2.2 Asia Montelukast Intermediate Sales by Application (2021-2032)
  8. 11.2.3 Asia Montelukast Intermediate Price by Application (2021-2032)
  9. 11.3 Asia Montelukast Intermediate Market Size by Country
  10. 11.3.1 Asia Montelukast Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Montelukast Intermediate Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Montelukast Intermediate Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Montelukast Intermediate Market Size by Type
  2. 12.1.1 SAMEA Montelukast Intermediate Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Montelukast Intermediate Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Montelukast Intermediate Price by Type (2021-2032)
  5. 12.2 SAMEA Montelukast Intermediate Market Size by Application
  6. 12.2.1 SAMEA Montelukast Intermediate Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Montelukast Intermediate Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Montelukast Intermediate Price by Application (2021-2032)
  9. 12.3 SAMEA Montelukast Intermediate Market Size by Country
  10. 12.3.1 SAMEA Montelukast Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Montelukast Intermediate Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Montelukast Intermediate Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Montelukast Intermediate Value Chain Analysis
  2. 13.1.1 Montelukast Intermediate Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Montelukast Intermediate Production Mode & Process
  6. 13.2 Montelukast Intermediate Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Montelukast Intermediate Distributors
  9. 13.2.3 Montelukast Intermediate Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst